Hamamoto, J., Yasuda, H., Aizawa, K., Nishino, M., Nukaga, S., Hirano, T., . . . Soejima, K. (2017). Non-small cell lung cancer PC-9 cells exhibit increased sensitivity to gemcitabine and vinorelbine upon acquiring resistance to EGFR-tyrosine kinase inhibitors. Oncol Lett.
Chicago-stil citatHamamoto, Junko, et al. "Non-small Cell Lung Cancer PC-9 Cells Exhibit Increased Sensitivity to Gemcitabine and Vinorelbine Upon Acquiring Resistance to EGFR-tyrosine Kinase Inhibitors." Oncol Lett 2017.
MLA-referensHamamoto, Junko, et al. "Non-small Cell Lung Cancer PC-9 Cells Exhibit Increased Sensitivity to Gemcitabine and Vinorelbine Upon Acquiring Resistance to EGFR-tyrosine Kinase Inhibitors." Oncol Lett 2017.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.